National Institute of Nursing Research; Notice of Meeting, 15165-15166 [2018-07117]
Download as PDF
<![CDATA[
15165
Federal Register / Vol. 83, No. 68 / Monday, April 9, 2018 / Notices
Number of
respondents
Form name
Number of
responses
per
respondent
Total
responses
Average
burden per
response
(in hours)
Total burden
hours
Telehealth Resource Center Performance Data Collection
Tool ...................................................................................
14
42
588
0.07
41
Total ..............................................................................
14
........................
588
........................
41
Dated: April 3, 2018.
Lori Roche,
Acting Deputy Director, Division of the
Executive Secretariat.
4. Access to Care Services and
Support to Patients;
5. Vaccine and Therapeutics; and
6. Other Tick-Borne Diseases and Coinfections.
DATES: May 10, 2018, from 8:30 a.m. to
6:30 p.m., Eastern Time.
ADDRESSES: This will be a virtual
meeting that is held via webcast.
Members of the public may attend the
meeting via webcast. Instructions for
attending this virtual meeting will be
posted one week prior to the meeting at:
https://www.hhs.gov/ash/advisorycommittees/tickbornedisease/
index.html.
[FR Doc. 2018–07175 Filed 4–6–18; 8:45 am]
FOR FURTHER INFORMATION CONTACT:
BILLING CODE 4165–15–P
James Berger, Office of HIV/AIDS and
Infectious Disease Policy, Office of the
Assistant Secretary for Health,
Department of Health and Human
Services; via email at tickbornedisease@
hhs.gov or by phone at 202–795–7697.
SUPPLEMENTARY INFORMATION: The
Working Group invites public comment
on issues related to the Working Group’s
charge. Comments may be provided
over the phone during the meeting or in
writing. Persons who wish to provide
comments by phone should review
directions at https://www.hhs.gov/ash/
advisory-committees/tickbornedisease/
meetings/ before submitting a
request via email at tickbornedisease@
hhs.gov on or before May 3, 2018. Phone
comments will be limited to three
minutes each to accommodate as many
speakers as possible. A total of 60
minutes will be allocated to public
comments. If more requests are received
than can be accommodated, speakers
will be randomly selected. The nature of
the comments will not be considered in
making this selection. Public comments
may also be provided in writing.
Individuals who would like to provide
written comment should review
directions at https://www.hhs.gov/ash/
advisory-committees/tickbornedisease/
meetings/ before sending
their comments to tickbornedisease@
hhs.gov on or before May 3, 2018.
Background and Authority: The TickBorne Disease Working Group was
established on August 10, 2017, in
accordance with section 2062 of the 21st
Century Cures Act, and the Federal
HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions, (2) the accuracy of the
estimated burden, (3) ways to enhance
the quality, utility, and clarity of the
information to be collected, and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Meeting of the Tick-Borne Disease
Working Group
Office of HIV/AIDS and
Infectious Disease Policy, Office of the
Assistant Secretary for Health, Office of
the Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
The Department of Health and
Human Services (HHS) announces the
fourth ‘‘on-line’’ meeting of the TickBorne Disease Working Group (Working
Group) on May 10, 2018, from 8:30 a.m.
to 6:30 p.m., Eastern Time. For this
fourth meeting, the Working Group will
focus on the findings and basis for the
draft reports from the work of the six
Subcommittee Working Groups that
were established on December 12, 2017.
These subcommittees were established
to assist the Working Group with the
development of the report to Congress
and the HHS Secretary as required by
the 21st Century Cures Act. The
subcommittees are:
1. Disease Vectors, Surveillance and
Prevention (includes epidemiology of
tick-borne diseases);
2. Pathogenesis, Transmission, and
Treatment;
3. Testing and Diagnostics (including
laboratory-based diagnoses and clinicaldiagnoses);
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:06 Apr 06, 2018
Jkt 244001
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Advisory Committee Act, 5 U.S.C. App.,
as amended, to provide expertise and
review all HHS efforts related to tickborne diseases to help ensure
interagency coordination and minimize
overlap, examine research priorities,
and identify and address unmet needs.
In addition, the Working Group will
report to the Secretary and Congress on
their findings and any recommendations
for the federal response to tick-borne
disease prevention, treatment, and
research, and addressing gaps in those
areas.
Dated: April 2, 2018.
James Berger,
Office of HIV/AIDS and Infectious Disease
Policy, Alternate Designated Federal Officer,
Tick-Borne Disease Working Group.
[FR Doc. 2018–07217 Filed 4–6–18; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research;
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council for Nursing Research.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The journals as potential
titles to be indexed by the National
Library of Medicine and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the journals as potential
titles to be indexed by the National
Library of Medicine, the disclosure of
E:\FR\FM\09APN1.SGM
09APN1
15166
Federal Register / Vol. 83, No. 68 / Monday, April 9, 2018 / Notices
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: National Advisory
Council for Nursing Research.
Date: May 15–16, 2018.
Open: May 15, 2018, 12:30 p.m. to 5:00
p.m.
Agenda: Discussion of Program Policies
and Issues.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C6 Room 6,
Bethesda, MD 20892.
Closed: May 16, 2018, 9:00 a.m. to 1:00
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, C6 Room 6,
Bethesda, MD 20892.
Contact Person: Marguerite Littleton
Kearney.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.National Advisory Council for Nursing
Research/National Institute of Nursing
Research, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.361, Nursing Research,
National Institutes of Health, HHS)
Dated: April 3, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–07117 Filed 4–6–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
sradovich on DSK3GMQ082PROD with NOTICES
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting of the Center for
Inherited Disease Research Access
Committee.
The meeting will be closed to the
public in accordance with the
VerDate Sep<11>2014
18:06 Apr 06, 2018
Jkt 244001
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Inherited
Disease Research Access Committee.
Date: May 4, 2018.
Time: 11:30 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Room 3049, Bethesda, MD
20892 (Telephone Conference Call).
Contact Person: Barbara J. Thomas, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, National Institutes of Health, 5635
Fishers Lane, Ste. 4076, MSC 9306, Bethesda,
MD 20892–9306, 301–402–0838,
barbara.thomas@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: April 3, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–07114 Filed 4–6–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Deafness and
Other Communication Disorders
Advisory Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Deafness and
Other Communication Disorders Advisory
Council.
Date: May 18, 2018.
Closed: 8:30 a.m. to 9:40 a.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Building 31, Conference Room 6, 31 Center
Drive, Bethesda, MD 20892.
Open: 9:40 a.m. to 2:00 p.m.
Agenda: Staff reports on divisional,
programmatical, and special activities.
Place: National Institutes of Health,
Building 31, Conference Room 6, 31 Center
Drive, Bethesda, MD 20892.
Contact Person: Craig A. Jordan, Ph.D.,
Director, Division of Extramural Activities,
NIDCD, NIH, Room 8345, MSC 9670, 6001
Executive Blvd., Bethesda, MD 20892–9670,
301–496–8693, jordanc@nidcd.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
www.nidcd.nih.gov/about/Pages/AdvisoryGroups-and-Review-Committees.aspx, where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: April 3, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–07116 Filed 4–6–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
E:\FR\FM\09APN1.SGM
09APN1
]]>Agencies
[Federal Register Volume 83, Number 68 (Monday, April 9, 2018)]
[Notices]
[Pages 15165-15166]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-07117]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Nursing Research; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Council for Nursing Research.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The journals as potential titles to be indexed by
the National Library of Medicine and the discussions could disclose
confidential trade secrets or commercial property such as patentable
material, and personal information concerning individuals associated
with the journals as potential titles to be indexed by the National
Library of Medicine, the disclosure of
[[Page 15166]]
which would constitute a clearly unwarranted invasion of personal
privacy.
Name of Committee: National Advisory Council for Nursing
Research.
Date: May 15-16, 2018.
Open: May 15, 2018, 12:30 p.m. to 5:00 p.m.
Agenda: Discussion of Program Policies and Issues.
Place: National Institutes of Health, Building 31, 31 Center
Drive, C6 Room 6, Bethesda, MD 20892.
Closed: May 16, 2018, 9:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Building 31, 31 Center
Drive, C6 Room 6, Bethesda, MD 20892.
Contact Person: Marguerite Littleton Kearney.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit.
Information is also available on the Institute's/Center's home
page: https://www.National Advisory Council for Nursing Research/
National Institute of Nursing Research, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.361,
Nursing Research, National Institutes of Health, HHS)
Dated: April 3, 2018.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-07117 Filed 4-6-18; 8:45 am]
BILLING CODE 4140-01-P
